Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.

<h4>Background</h4>The relevance to coronary heart disease (CHD) of cytokines that govern inflammatory cascades, such as interleukin-6 (IL-6), may be underestimated because such mediators are short acting and prone to fluctuations. We evaluated associations of long-term circulating IL-6...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: John Danesh, Stephen Kaptoge, Andrea G Mann, Nadeem Sarwar, Angela Wood, Sara B Angleman, Frances Wensley, Julian P T Higgins, Lucy Lennon, Gudny Eiriksdottir, Ann Rumley, Peter H Whincup, Gordon D O Lowe, Vilmundur Gudnason
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2008
Materias:
R
Acceso en línea:https://doaj.org/article/001404b6e23c41e6bbfe7de85d5cc2e6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:001404b6e23c41e6bbfe7de85d5cc2e6
record_format dspace
spelling oai:doaj.org-article:001404b6e23c41e6bbfe7de85d5cc2e62021-12-02T19:55:56ZLong-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.1549-12771549-167610.1371/journal.pmed.0050078https://doaj.org/article/001404b6e23c41e6bbfe7de85d5cc2e62008-04-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18399716/?tool=EBIhttps://doaj.org/toc/1549-1277https://doaj.org/toc/1549-1676<h4>Background</h4>The relevance to coronary heart disease (CHD) of cytokines that govern inflammatory cascades, such as interleukin-6 (IL-6), may be underestimated because such mediators are short acting and prone to fluctuations. We evaluated associations of long-term circulating IL-6 levels with CHD risk (defined as nonfatal myocardial infarction [MI] or fatal CHD) in two population-based cohorts, involving serial measurements to enable correction for within-person variability. We updated a systematic review to put the new findings in context.<h4>Methods and findings</h4>Measurements were made in samples obtained at baseline from 2,138 patients who had a first-ever nonfatal MI or died of CHD during follow-up, and from 4,267 controls in two cohorts comprising 24,230 participants. Correction for within-person variability was made using data from repeat measurements taken several years apart in several hundred participants. The year-to-year variability of IL-6 values within individuals was relatively high (regression dilution ratios of 0.41, 95% confidence interval [CI] 0.28-0.53, over 4 y, and 0.35, 95% CI 0.23-0.48, over 12 y). Ignoring this variability, we found an odds ratio for CHD, adjusted for several established risk factors, of 1.46 (95% CI 1.29-1.65) per 2 standard deviation (SD) increase of baseline IL-6 values, similar to that for baseline C-reactive protein. After correction for within-person variability, the odds ratio for CHD was 2.14 (95% CI 1.45-3.15) with long-term average ("usual") IL-6, similar to those for some established risk factors. Increasing IL-6 levels were associated with progressively increasing CHD risk. An updated systematic review of electronic databases and other sources identified 15 relevant previous population-based prospective studies of IL-6 and clinical coronary outcomes (i.e., MI or coronary death). Including the two current studies, the 17 available prospective studies gave a combined odds ratio of 1.61 (95% CI 1.42-1.83) per 2 SD increase in baseline IL-6 (corresponding to an odds ratio of 3.34 [95% CI 2.45-4.56] per 2 SD increase in usual [long-term average] IL-6 levels).<h4>Conclusions</h4>Long-term IL-6 levels are associated with CHD risk about as strongly as are some major established risk factors, but causality remains uncertain. These findings highlight the potential relevance of IL-6-mediated pathways to CHD.John DaneshStephen KaptogeAndrea G MannNadeem SarwarAngela WoodSara B AnglemanFrances WensleyJulian P T HigginsLucy LennonGudny EiriksdottirAnn RumleyPeter H WhincupGordon D O LoweVilmundur GudnasonPublic Library of Science (PLoS)articleMedicineRENPLoS Medicine, Vol 5, Iss 4, p e78 (2008)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
John Danesh
Stephen Kaptoge
Andrea G Mann
Nadeem Sarwar
Angela Wood
Sara B Angleman
Frances Wensley
Julian P T Higgins
Lucy Lennon
Gudny Eiriksdottir
Ann Rumley
Peter H Whincup
Gordon D O Lowe
Vilmundur Gudnason
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.
description <h4>Background</h4>The relevance to coronary heart disease (CHD) of cytokines that govern inflammatory cascades, such as interleukin-6 (IL-6), may be underestimated because such mediators are short acting and prone to fluctuations. We evaluated associations of long-term circulating IL-6 levels with CHD risk (defined as nonfatal myocardial infarction [MI] or fatal CHD) in two population-based cohorts, involving serial measurements to enable correction for within-person variability. We updated a systematic review to put the new findings in context.<h4>Methods and findings</h4>Measurements were made in samples obtained at baseline from 2,138 patients who had a first-ever nonfatal MI or died of CHD during follow-up, and from 4,267 controls in two cohorts comprising 24,230 participants. Correction for within-person variability was made using data from repeat measurements taken several years apart in several hundred participants. The year-to-year variability of IL-6 values within individuals was relatively high (regression dilution ratios of 0.41, 95% confidence interval [CI] 0.28-0.53, over 4 y, and 0.35, 95% CI 0.23-0.48, over 12 y). Ignoring this variability, we found an odds ratio for CHD, adjusted for several established risk factors, of 1.46 (95% CI 1.29-1.65) per 2 standard deviation (SD) increase of baseline IL-6 values, similar to that for baseline C-reactive protein. After correction for within-person variability, the odds ratio for CHD was 2.14 (95% CI 1.45-3.15) with long-term average ("usual") IL-6, similar to those for some established risk factors. Increasing IL-6 levels were associated with progressively increasing CHD risk. An updated systematic review of electronic databases and other sources identified 15 relevant previous population-based prospective studies of IL-6 and clinical coronary outcomes (i.e., MI or coronary death). Including the two current studies, the 17 available prospective studies gave a combined odds ratio of 1.61 (95% CI 1.42-1.83) per 2 SD increase in baseline IL-6 (corresponding to an odds ratio of 3.34 [95% CI 2.45-4.56] per 2 SD increase in usual [long-term average] IL-6 levels).<h4>Conclusions</h4>Long-term IL-6 levels are associated with CHD risk about as strongly as are some major established risk factors, but causality remains uncertain. These findings highlight the potential relevance of IL-6-mediated pathways to CHD.
format article
author John Danesh
Stephen Kaptoge
Andrea G Mann
Nadeem Sarwar
Angela Wood
Sara B Angleman
Frances Wensley
Julian P T Higgins
Lucy Lennon
Gudny Eiriksdottir
Ann Rumley
Peter H Whincup
Gordon D O Lowe
Vilmundur Gudnason
author_facet John Danesh
Stephen Kaptoge
Andrea G Mann
Nadeem Sarwar
Angela Wood
Sara B Angleman
Frances Wensley
Julian P T Higgins
Lucy Lennon
Gudny Eiriksdottir
Ann Rumley
Peter H Whincup
Gordon D O Lowe
Vilmundur Gudnason
author_sort John Danesh
title Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.
title_short Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.
title_full Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.
title_fullStr Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.
title_full_unstemmed Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.
title_sort long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.
publisher Public Library of Science (PLoS)
publishDate 2008
url https://doaj.org/article/001404b6e23c41e6bbfe7de85d5cc2e6
work_keys_str_mv AT johndanesh longterminterleukin6levelsandsubsequentriskofcoronaryheartdiseasetwonewprospectivestudiesandasystematicreview
AT stephenkaptoge longterminterleukin6levelsandsubsequentriskofcoronaryheartdiseasetwonewprospectivestudiesandasystematicreview
AT andreagmann longterminterleukin6levelsandsubsequentriskofcoronaryheartdiseasetwonewprospectivestudiesandasystematicreview
AT nadeemsarwar longterminterleukin6levelsandsubsequentriskofcoronaryheartdiseasetwonewprospectivestudiesandasystematicreview
AT angelawood longterminterleukin6levelsandsubsequentriskofcoronaryheartdiseasetwonewprospectivestudiesandasystematicreview
AT sarabangleman longterminterleukin6levelsandsubsequentriskofcoronaryheartdiseasetwonewprospectivestudiesandasystematicreview
AT franceswensley longterminterleukin6levelsandsubsequentriskofcoronaryheartdiseasetwonewprospectivestudiesandasystematicreview
AT julianpthiggins longterminterleukin6levelsandsubsequentriskofcoronaryheartdiseasetwonewprospectivestudiesandasystematicreview
AT lucylennon longterminterleukin6levelsandsubsequentriskofcoronaryheartdiseasetwonewprospectivestudiesandasystematicreview
AT gudnyeiriksdottir longterminterleukin6levelsandsubsequentriskofcoronaryheartdiseasetwonewprospectivestudiesandasystematicreview
AT annrumley longterminterleukin6levelsandsubsequentriskofcoronaryheartdiseasetwonewprospectivestudiesandasystematicreview
AT peterhwhincup longterminterleukin6levelsandsubsequentriskofcoronaryheartdiseasetwonewprospectivestudiesandasystematicreview
AT gordondolowe longterminterleukin6levelsandsubsequentriskofcoronaryheartdiseasetwonewprospectivestudiesandasystematicreview
AT vilmundurgudnason longterminterleukin6levelsandsubsequentriskofcoronaryheartdiseasetwonewprospectivestudiesandasystematicreview
_version_ 1718375819690115072